AGTR1 inhibitor nanoconjugate boosts chemo, immunotherapies in cancers

By Sandi Wong | May 6, 2019 | 7:24 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Pancreatic cancer; breast cancer

Mouse studies suggest a nanoconjugate based on the generic ATGR1 inhibitor valsartan could enhanced the efficacy of chemotherapies and checkpoint inhibitors in pancreatic and

Read the full 303 word article

How to gain access

Continue reading with a
two-week free trial.